This unprecedented efficacy is paired with extremely low side-effects without clinically relevant immune suppression (e.g., opportunistic infections) in clinical trials and real-world observations, which corresponds to the protection of individuals with hypomorphic IL23R function. This evidence concerns the gene IL23R and Opportunistic infection.